Home/Filings/4/0001156039-23-000027
4//SEC Filing

Kendrick Charles Morgan JR 4

Accession 0001156039-23-000027

CIK 0001156039other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 4:19 PM ET

Size

11.7 KB

Accession

0001156039-23-000027

Insider Transaction Report

Form 4
Period: 2023-03-01
Kendrick Charles Morgan JR
EVP & President, Commercial
Transactions
  • Tax Payment

    Common Stock

    2023-03-01$469.03/sh293$137,42614,157 total
  • Award

    Common Stock

    2023-03-01+2,02616,183 total
  • Award

    Common Stock

    2023-03-01+2,54218,725 total
  • Tax Payment

    Common Stock

    2023-03-02$468.78/sh1,084$508,15817,641 total
  • Award

    Employee Stock Option (Right to Buy)

    2023-03-01+7,7867,786 total
    Exercise: $469.03Exp: 2033-03-01Common Stock (7,786 underlying)
Footnotes (4)
  • [F1]PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
  • [F2]Represents restricted share units. Restrictions lapse as follows: 675 shares each on 3/1/2024 and 3/1/2025 and 676 shares on 3/1/2026.
  • [F3]Represents performance based restricted share units. Restrictions lapse on 3/2/2023.
  • [F4]The option represents a right to purchase a total of 7,786 shares, and is exercisable in two installments of 2,595 shares each and one installment of 2,596 shares, beginning on 3/1/2024 which is the one-year anniversary of the option grant date.

Issuer

Elevance Health, Inc.

CIK 0001156039

Entity typeother

Related Parties

1
  • filerCIK 0001887908

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:19 PM ET
Size
11.7 KB